The prospects for PBIO after bookkeeping debacle

The prospects for PBIO after bookkeeping debacle

PerSeptive BioSystems Inc. shares lost nearly a quarter of their value last week after the company restated the results for its past two fiscal years and reported a net loss of $34 million for the fiscal year ended Sept. 30. But the biotechnology instrument manufacturer could turn profitable in 1995, according to Cowen & Co.

Read the full 621 word article

How to gain access

Continue reading with a
two-week free trial.